Canakinumab Subcutaneous and Empagliflozin and metformin
Determining the interaction of Canakinumab Subcutaneous and Empagliflozin and metformin and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: canakinumab
Brand name: Ilaris
Synonyms: Canakinumab
Generic Name: empagliflozin / metformin
Brand name: Synjardy, Synjardy XR
Synonyms: Empagliflozin and Metformin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Canakinumab Subcutaneous-Empagliflozin and Metformin Extended-Release Tablets
- Canakinumab Subcutaneous-Empagliflozin and Metformin Tablets
- Canakinumab Subcutaneous-Empliciti
- Canakinumab Subcutaneous-Emsam
- Canakinumab Subcutaneous-Emsam Transdermal
- Canakinumab Subcutaneous-Emtricitabine
- Empagliflozin and metformin-Canasa
- Empagliflozin and metformin-Canasa Pac rectal
- Empagliflozin and metformin-Canasa rectal
- Empagliflozin and metformin-Cancidas
- Empagliflozin and metformin-Candesartan
- Empagliflozin and metformin-Candesartan and Hydrochlorothiazide